[vc_row][vc_column][vc_column_text css=”.vc_custom_1665706747362{padding-bottom: 40px !important;}”]

Abstract acknowledgement

You will receive an email acknowledging receipt of your abstract submission. If you do not receive this email and, after checking your spam/junk folder, please contact Expert Events via acpe@expertevents.com.au.

Enquiries

All enquiries regarding abstracts and the submission process should be directed to the ACPE14 Program Secretariat, Expert Events.
Expert Events
PO Box 351, Hamilton Central QLD 4007 Australia
Tel: +61 7 3848 2100 | Email: acpe@expertevents.com.au[/vc_column_text][accordion_father][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Guidelines for abstract submission”]Research abstracts are eligible, whether or not their content has been presented at meetings of other scientific societies, as long as they meet the following criteria:

• relevant to the field of pharmacoepidemiology as broadly defined
• results have not been published (except in abstract form) either on-line or in printed full form before January 1 of the year of the meeting, and
• results have not been presented at a previous ISPE meeting.

The first author listed for each abstract is considered to be the presenting author who will be the primary contact for all correspondence regarding the abstract.

Abstracts must be submitted in English.

Presenter Registration
All presenting authors must have registered and paid to attend the conference by Friday 26 August 2022.[/accordion_son][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Presentation Types”]Oral Presentation: 15 minutes (10 minutes for presentation and 5 minutes questions).

Option 1: Presenting in-person at the conference venue, National Cheng Kung University, Tainan, Taiwan.

Option 2: Presenting via a pre-recorded video and attending virtually for audience questions. This option is for presenters who are unable to travel to attend the conference. Consideration will be given to the country and location of speakers when scheduling them in the program.

The on-site technology will allow for both in-person and virtual attendees to ask questions of the presenters. Consideration will be given to the country and location of speakers when scheduling them in the program.

The deadline for accepted oral presenters to submit their pre-recorded presentation is Friday 30 September.

ePoster Presentation:
All attendees, whether attending in-person or online, will prepare a 3-minute pre-recorded presentation with 3 slides. Pre-recorded e-Poster presentations will be available for conference delegates to view at their convenience through the conference website.

The deadline for accepted poster presenters to submit their e-Poster presentation is Friday 30 September.

Spotlight Posters:
A number of notable ePosters will be pre-selected for the Spotlight Poster Session. These poster presenters will be invited to deliver a 3-minute oral description of their work in English, followed by audience discussions moderated by a senior ISPE member. Successful presenters will be notified on Monday 5 September 2022.[/accordion_son][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Abstract submission topics:”]A.  Pharmaceutical policy and administration

B.  Pharmacoepidemiology and Pharmacovigilance research methods

C.  Drug safety risk monitoring, evaluation and prevention

D.  Pharmacogenomics research and drug safety

E.  Evidence-based medicine

F.  Evidence-based pharmacy

G.  Drug utilization evaluation studies

H.  Rational drug use

I.  Pharmacoepidemiology and traditional medicines

J.  Prevention of medication errors and drug misuse/abuse

K.  Rare disease and orphan medicines

L.  Post-marketing drug effectiveness and safety evaluation

M.  Prevention and treatment of drug-induced diseases

N.  Other related fields[/accordion_son][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Abstract format”]Abstract title: must not exceed 20 words.

Abstract text: must not exceed 300 words (excluding the Title, Authors, and Affiliations).

Do not reference institution names, locations, or funding sources in the abstract.

Abstracts should include the following headings:
Aim/Objective:
Methods:
Results:
Conclusion:
Keywords: list not more than four keywords describing your research.

Graphics and tables cannot be submitted as part of your abstract.

Author names and affiliations:

Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.

Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.

Abstracts which are not correctly formatted will not be reviewed.[/accordion_son][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Abstract review process”]All submitted abstracts will be reviewed by at least 3 reviewers.

In evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract. (Abstracts will be suitably anonymised by the program secretariat before being sent out to reviewers).

The Program Committee will assign accepted abstracts either to oral or poster presentation, and the reviewers’ decision is final.[/accordion_son][accordion_son title_padding=”12″ size=”” borderwidth=”0px 0px 1px 0px” title=”Notification of Acceptance”]The Organising Committee reserves the right to accept or decline any submissions and to select the presentation format.

Presenting authors will be notified of their acceptance status on Friday 15 July 2022 and must inform any co-author(s).

Presenter Registration
All presenting authors must have registered and paid to attend the conference by Friday 26 August 2022.

Accepted abstracts will be published in the conference program only if the presenting author has registered for the conference[/accordion_son][/accordion_father][/vc_column][/vc_row]